Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy

Author： Tanko L. B.   Christiansen C.  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.9, Iss.3, 2006-06, pp. : 169-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen and progestogen therapy in postmenopausal women

By The Practice Committee of the American Society for Reproductive Medicine  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 231-241

Elsevier

Access to resources Recommend Favorite

Is combined estrogen/progestogen hormone therapy worth the risk?

By Sturdee David W.   MacLennan Alastair H.  

Climacteric, Vol. 6, Iss. 3, 2003-09 ,pp. : 177-179

Informa Healthcare

Access to resources Recommend Favorite

Smoking reduces breast tenderness during oral estrogen-progestogen therapy

By Bjarnason NH   Jørgensen C   Kremmer H   Alexandersen P   Christiansen C  

Climacteric, Vol. 7, Iss. 4, 2004-12 ,pp. : 390-396

Informa Healthcare

Access to resources Recommend Favorite

Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus® study

By Wierik EJM Velthuis-te   Hendricks PT   Boerstoel-Streefland M.  

Climacteric, Vol. 7, Iss. 2, 2004-06 ,pp. : 197-209

Informa Healthcare

Access to resources Recommend Favorite

Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women

By Villa P.   Sagnella F.   Perri C.   Suriano R.   Costantini B.   Macri F.   Ricciardi L.   Lanzone A.  

Climacteric, Vol. 11, Iss. 6, 2008-01 ,pp. : 498-508

Informa Healthcare

Access to resources Recommend Favorite